TEK and glioblastoma: In particular, Scholz et al. [37] previously also demonstrated a decrease in glioblastoma vessel density after either radiochemotherapy or radiochemotherapy plus bevacizumab and described concurrent changes in the angiopoietin/Tie2 signaling pathway.